Vanguard Group’s Lumexa Imaging Holdings LMRI Stock Holding History

Vanguard Group’s Portfolio LMRI Stock Details LMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$4.26M	Buy	+230,000	New	+$4.15M	﹤0.01%	3318

Other funds holding LMRI

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group's LMRI Position: Q4 2025 in Review

Vanguard Group opened a new position in Lumexa Imaging Holdings (LMRI) in Q4 2025: 230,000 shares worth $4.26M. The stake represents ﹤0.01% of the portfolio and ranks #3318 among its holdings.

62 funds tracked by Wall St. Rank hold LMRI as of Q4 2025.

Vanguard Group held 230,000 shares of Lumexa Imaging Holdings worth $4.26M as of Q4 2025.
Lumexa Imaging Holdings was a new Vanguard Group position in Q4 2025.
Lumexa Imaging Holdings made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3318 holding.
62 funds tracked by Wall St. Rank held Lumexa Imaging Holdings as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.